SCHEMBL20190679

SCHEMBL20190679

O=[N+]([O-])c1cnccc1OC(F)(F)CF

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.40
ALDH1A1 P00352 5/20 0.40
RAB9A P51151 2/20 0.40
MAPT P10636 7/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 2/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20189613 0.78 CYP17A1 (0.41) HTTALDH1A1RAB9AMAPTLMNA
SCHEMBL187850 0.73 ALDH1A1 (0.56) HTTALDH1A1RAB9AGAAMEN1
SCHEMBL3488943 0.72 ALDH1A1 (0.50) HTTALDH1A1RAB9AMAPTLMNA
SCHEMBL8559820 0.72 MAPT (0.42) HTTALDH1A1RAB9AMAPTLMNA
SCHEMBL16702893 0.72 ALDH1A1 (0.41) HTTALDH1A1RAB9AMAPTLMNA
SCHEMBL7833144 0.72 TDP1 (0.49) HTTALDH1A1RAB9AMAPTGAA
SCHEMBL16703853 0.72 HTT (0.40) HTTALDH1A1RAB9AMAPTLMNA
SCHEMBL1414586 0.71 ALDH5A1 (0.48) HTTALDH1A1MAPTLMNAMEN1
SCHEMBL3594746 0.71 POLB (0.43) RAB9AMAPTMEN1KMT2APOLB
Hydrochloric Acid SCHEMBL3601018 0.71 ALDH1A1 (0.55) HTTALDH1A1RAB9AGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544980-A1 GSK-3 INHIBITORS Bristol-Myers Squibb Company (US) 2019-10-02 EP disclosed
WO-2018098411-A1 GSK-3 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-31 WO disclosed